Pharmaceutical News

RSS

UQ spin-off company to develop precision painkillers for treating debilitating conditions

Precision painkillers that are more accurate and less harmful to the liver are set to be developed by a University of Queensland spin-off company -; potentially changing the lives of millions of people.

3 Nov 2022

Bivalent mRNA booster broadens humoral immunity against SARS-CoV-2 Omicron subvariants

Researchers at Emory University, Stanford University, and the National Institute of Allergy and Infectious Diseases evaluated whether bivalent coronavirus disease 2019 (COVID-19) boosters conferred protection against new Omicron subvariants.

2 Nov 2022

Study suggests oral cephalosporins as safe, effective alternative for treating acute kidney infections

A new study led by Ochsner infectious diseases clinical pharmacist Kevin Lin, PharmD, was recently published in PLoS One, suggesting that oral cephalosporins are as safe and effective as the standard of care fluoroquinolones (FQs) for the treatment of acute kidney infections.

2 Nov 2022

The maternal RSV vaccine from Pfizer protects newborns against severe illness

Pfizer announced its maternal vaccine against RSV to be almost 82% effective in protecting infants for the first 90 days of life against severe illness.

1 Nov 2022

UH PREMIER Center receives funding to fight the rising tide of opioid addiction and death

Fighting the rising tide of opioid addiction and death, the Prescription Drug Misuse Education and Research (PREMIER) Center at the University of Houston College of Pharmacy has been funded for the next two years by the Texas Health and Human Services Commission for an additional $3.34 million.

31 Oct 2022

An innovative nasal vaccine strategy to combat COVID

In a recent study published in the journal Science, researchers at Yale University developed a novel coronavirus disease 2019 (COVID-19) vaccination strategy termed 'prime and spike' (P&S) that leveraged existing systemic immunity triggered by parenteral vaccination (prime) to boost immunity at the respiratory mucosa.

31 Oct 2022

Indonesian government orders temporary ban of cough syrups after Gambian tragedy

Following a WHO warning about possible toxic ingredients in four cough syrups of Indian origin, the Indonesian government has ordered a temporary ban on all liquid medicines in the country over reported spike in children's deaths linked to medical syrups.

28 Oct 2022

Scientists computationally restore the potency of an antibody against SARS-CoV-2 Omicron subvariants

A team of researchers from the United States computationally modified the COV2-2130 monoclonal antibody to restore its neutralizing ability against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron subvariants, while retaining efficacy against the Delta and wild-type strains.

27 Oct 2022

Updapted BA.4/5 COVID vaccines boost protection but might not surpass original formula

In a recent study posted to the bioRxiv* preprint server, researchers at Beth Israel Deaconess Medical Center assessed the immunogenicity associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) BA.5 bivalent messenger ribonucleic acid (mRNA) vaccine boosters.

27 Oct 2022

$38,398 for a single shot of a very old cancer drug

Dr. Josie Tenore and Paul Hinds were introduced by a mutual friend in 2017 and hadn't been going out long when she laid down the law: He had to get a physical.

26 Oct 2022

Study highlights the need to strengthen trust in healthcare to limit antibiotic use

Do many Swedes obtain antibiotics without a prescription, and what drives their behaviour when this happens? The answers are important when it comes to dealing with antibiotic resistance, which is a serious challenge for the entire healthcare sector.

24 Oct 2022

New study highlights how pain management practices are changing after surgery

Although there has been no decrease in the number of opioid prescriptions seniors receive after surgery, the doses of those prescriptions are lower, according to a study of more than a quarter million Canadian patients being presented at the ANESTHESIOLOGY 2022 annual meeting.

24 Oct 2022

Regular statin use may reduce the risk of death and severity of COVID-19

Commonly used cholesterol-lowering statins may reduce the risk of death and severity of COVID-19 disease, suggests a study of more than 38,000 patients being presented at the ANESTHESIOLOGY 2022 annual meeting.

24 Oct 2022

A study of Moderna's COVID vaccine in children aged 6 months to 5 years

In a recent study published in the New England Journal of Medicine, researchers presented the findings of the ongoing KidCOVE trial in the United States (US).

23 Oct 2022

Booster vaccinations in the elderly lead to impaired neutralization of SARS-CoV-2 and atypical B cells

Researchers examine neutralizing antibody responses against SARS-CoV-2 in elderly individuals who received one mRNA booster dose.

23 Oct 2022

Researchers assess the dependence potential and abuse liability of delta-8-THC

One is an illegal drug found in marijuana while the other is marketed as a safe herbal alternative. But the claimed differences between them aren't backed by science, a group of UConn researchers report on Nov. 1 in Drug and Alcohol Dependence.

21 Oct 2022

Analgesic use after COVID-19 vaccination does not negatively affect antibody responses

In a recent study posted to the medRxiv* preprint server, University of Arizona researchers assessed the relationship between antibody responses and analgesic usage after coronavirus disease 2019 (COVID-19) vaccination.

20 Oct 2022

KHN’s ‘What the Health?’: Biden hits the road to sell Democrats’ record

What do pandemic preparedness, mental health care services, and over-the-counter hearing aids have in common? They are all things President Joe Biden touted on the campaign trail this week as he tries to maintain Democrats' majorities in Congress in the midterm elections Nov. 8.

20 Oct 2022

Licorice root extract shows potential as a COVID-19 treatment

A recent study explores the activity of glycyrrhizin against SARS-CoV-2.

19 Oct 2022

Rapid and robust pipeline for developing mRNA vaccines for future SARS-CoV-2 variants

A recent study under review at the journal Scientific Reports and currently available on the Research Square* preprint server reported the development of a robust pipeline for fabricating an mRNA vaccine portfolio to combat current and future coronavirus outbreaks, other infectious diseases, and cancer.

19 Oct 2022

Previous
1
...
65
66
67
68
69
70
71
...
1433
Next

Pharmaceutical News

UQ spin-off company to develop precision painkillers for treating debilitating conditions

Bivalent mRNA booster broadens humoral immunity against SARS-CoV-2 Omicron subvariants

Study suggests oral cephalosporins as safe, effective alternative for treating acute kidney infections

The maternal RSV vaccine from Pfizer protects newborns against severe illness

UH PREMIER Center receives funding to fight the rising tide of opioid addiction and death

An innovative nasal vaccine strategy to combat COVID

Indonesian government orders temporary ban of cough syrups after Gambian tragedy

Scientists computationally restore the potency of an antibody against SARS-CoV-2 Omicron subvariants

Updapted BA.4/5 COVID vaccines boost protection but might not surpass original formula

$38,398 for a single shot of a very old cancer drug

Study highlights the need to strengthen trust in healthcare to limit antibiotic use

New study highlights how pain management practices are changing after surgery

Regular statin use may reduce the risk of death and severity of COVID-19

A study of Moderna's COVID vaccine in children aged 6 months to 5 years

Booster vaccinations in the elderly lead to impaired neutralization of SARS-CoV-2 and atypical B cells

Researchers assess the dependence potential and abuse liability of delta-8-THC

Analgesic use after COVID-19 vaccination does not negatively affect antibody responses

KHN’s ‘What the Health?’: Biden hits the road to sell Democrats’ record

Licorice root extract shows potential as a COVID-19 treatment

Rapid and robust pipeline for developing mRNA vaccines for future SARS-CoV-2 variants

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News